Thomas F Patterson
Thomas F Patterson
Professor of Medicine, The University of Texas Health Science Center at San Antonio
Dirección de correo verificada de uthscsa.edu
Título
Citado por
Citado por
Año
Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and the national …
B De Pauw, TJ Walsh, JP Donnelly, DA Stevens, JE Edwards, T Calandra, ...
Clinical infectious diseases 46 (12), 1813-1821, 2008
47742008
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis
R Herbrecht, DW Denning, TF Patterson, JE Bennett, RE Greene, ...
New England Journal of Medicine 347 (6), 408-415, 2002
34472002
Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America
TJ Walsh, EJ Anaissie, DW Denning, R Herbrecht, DP Kontoyiannis, ...
Clinical infectious diseases 46 (3), 327-360, 2008
32922008
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus
S Ascioglu, JH Rex, B De Pauw, JE Bennett, J Bille, F Crokaert, ...
Проблемы медицинской микологии 5 (1), 2003
27102003
Remdesivir for the treatment of Covid-19—preliminary report
JH Beigel, KM Tomashek, LE Dodd, AK Mehta, BS Zingman, AC Kalil, ...
New England Journal of Medicine, 2020
18982020
Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America
TF Patterson, GR Thompson III, DW Denning, JA Fishman, S Hadley, ...
Clinical Infectious Diseases 63 (4), e1-e60, 2016
16022016
Remdesivir for the treatment of Covid-19
JH Beigel, KM Tomashek, LE Dodd, AK Mehta, BS Zingman, AC Kalil, ...
New England Journal of Medicine 383 (19), 1813-1826, 2020
15612020
Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001–2006: overview of the Transplant-Associated Infection …
DP Kontoyiannis, KA Marr, BJ Park, BD Alexander, EJ Anaissie, TJ Walsh, ...
Clinical Infectious Diseases 50 (8), 1091-1100, 2010
12982010
Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)
PG Pappas, BD Alexander, DR Andes, S Hadley, CA Kauffman, A Freifeld, ...
Clinical Infectious Diseases 50 (8), 1101-1111, 2010
12442010
Practice guidelines for diseases caused by Aspergillus
DA Stevens, VL Kan, MA Judson, VA Morrison, S Dummer, DW Denning, ...
Clinical Infectious Diseases, 696-709, 2000
10732000
Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group.
TF Patterson, WR Kirkpatrick, M White, JW Hiemenz, JR Wingard, ...
Medicine 79 (4), 250-260, 2000
9742000
Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial
TJ Walsh, I Raad, TF Patterson, P Chandrasekar, GR Donowitz, R Graybill, ...
Clinical infectious diseases 44 (1), 2-12, 2007
7752007
Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy
J Maertens, I Raad, G Petrikkos, M Boogaerts, D Selleslag, FB Petersen, ...
Clinical Infectious Diseases 39 (11), 1563-1571, 2004
7452004
Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign
RE Greene, HT Schlamm, JW Oestmann, P Stark, C Durand, O Lortholary, ...
Clinical Infectious Diseases 44 (3), 373-379, 2007
6592007
European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study …
B De Pauw, TJ Walsh, JP Donnelly, DA Stevens, JE Edwards, T Calandra, ...
Clin Infect Dis 46 (12), 1813-1821, 2008
6282008
Prevalence of Molecular Mechanisms of Resistance to Azole Antifungal Agents in Candida albicans Strains Displaying High-Level Fluconazole Resistance Isolated …
S Perea, JL López-Ribot, WR Kirkpatrick, RK McAtee, RA Santillán, ...
Antimicrobial agents and chemotherapy 45 (10), 2676-2684, 2001
5662001
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled …
JA Maertens, II Raad, KA Marr, TF Patterson, DP Kontoyiannis, ...
The Lancet 387 (10020), 760-769, 2016
5322016
Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms
G Ramage, S Bachmann, TF Patterson, BL Wickes, JL López-Ribot
Journal of Antimicrobial Chemotherapy 49 (6), 973-980, 2002
4952002
Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group: Voriconazole versus amphotericin B …
R Herbrecht
N. Eng. J. Med. 347, 408-415, 2002
4532002
Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group …
JP Donnelly, SC Chen, CA Kauffman, WJ Steinbach, JW Baddley, ...
Clinical Infectious Diseases 71 (6), 1367-1376, 2020
4312020
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20